1e
19
1
49
2
2
18
1b
1d
18
2e
5a
1d
2 29
1d
25
Lisa M. Wray, MD
88
5a
Associate Professor of Clinical Pediatrics (Oncology)
28
85
3
61
Attending Physician, Division of Oncology, Children's Hospital of Philadelphia
93
Director, Pediatric Cancer Immunotherapy/BMT Fellowship, Children's Hospital of Philadelphia
11
Department: Pediatrics
4
1
b
1d
46
Contact information
51
4
3
3
3
2
4
b
1f
51
Children's Hospital of Philadelphia
1c Division of Oncology
39 3401 Civic Center Blvd
Philadelphia, PA 19104
26
1c Division of Oncology
39 3401 Civic Center Blvd
Philadelphia, PA 19104
35
f
13
Education:
21 7 BS 2d (Biochemistry & Molecular Biology) c
53 The Pennsylvania State University, Schreyer Honors College, 1999.
21 7 BS 36 (French - Technical Writing & Translation ) c
53 The Pennsylvania State University, Schreyer Honors College, 1999.
21 7 MD c
3d Temple University School of Medicine, 2006.
c
3
3
3
3
8a
Permanent link21 7 BS 2d (Biochemistry & Molecular Biology) c
53 The Pennsylvania State University, Schreyer Honors College, 1999.
21 7 BS 36 (French - Technical Writing & Translation ) c
53 The Pennsylvania State University, Schreyer Honors College, 1999.
21 7 MD c
3d Temple University School of Medicine, 2006.
c
2 29
21
1e
1d
24
2b
29
27
23
17e Friedes BD, DiNofia AM, Iannone E, Li Y, Rheingold SR, Leahy AB, Wray L, Callahan C, Baniewicz D, Vernau L, Getz KD, Aplenc R, Maude SL, Grupp SA, Myers RM.: Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy. Blood Adv 9: 354-359, Jan 2025.
1a3 Diorio C, Hernandez-Miyares L, Espinoza DA, Banwell BL, Bar-Or A, DiNofia AM, Barz Leahy A, Martinez Z, Myers RM, Hopkins SE, Rheingold SR, Teachey DT, Viaene AN, Wray LM, Maude SL, Grupp SA, McGuire JL.: Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents. Blood 144: 1387-1398, Sep 2024.
1d9 Myers RM, Devine K, Li Y, Lawrence S, Leahy AB, Liu H, Vernau L, Callahan C, Baniewicz D, Kadauke S, McGuire R, Wertheim GB, Kulikovskaya I, Gonzalez VE, Fraietta JA, DiNofia AM, Hunger SP, Rheingold SR, Aplenc R, June CH, Grupp SA, Wray L, Maude SL.: Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia. Blood Adv 8: 2182-2192, May 2024.
130 Oved JH, Gibson NM, Venella K, Elgarten CW, Wray L, Warren JT, Olson TS.: Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia. Front Immunol 15: 1369243, Feb 2024.
1d0 Elgarten CW, Heidemann S, Freedman JL, Grupp SA, Hankins P, Kadauke S, Li Y, McGlynn B, Olson TS, Wang Y, Wray L, Wang L, Seif AE, Bunin NJ: Pilot Study of Unrelated Donor (URD) Peripheral Stem Cell Transplant (PSCT) with CD45RA-Depleted Addback Following TCRab/CD19 Depletion in Pediatric Patients with Hematologic Malignancies Transplantation and Cellular Therapy 30(2): S9-S10, Feb 2024.
190 Gibson NM, Elgarten CW, Oved JH, Wray L, Freedman JL, Wang Y, Kadauke S, Hankins P, Nicholas P, Worster E, Kwiatkowski JL, Grupp SA, Bunin NJ, Olson TS: Outcomes of Unrelated Partial T Cell Depleted Stem Cell Transplantation for Patients with Hemoglobinopathies. Transplantation and Cellular Therapy 30(2): S301-S302, Feb 2024.
1e4 Myers RM, Mumanachit S, Maude SL, Dinofia AM, Freedman JL, Bunin N, Wray L, Barz AL, Olson TS, Grupp S, Seif AE, Elgarten CW: 3767 Outcomes and Toxicities after Allogeneic Hematopoietic Cell Transplant for Remission Consolidation or Relapse Therapy after CD19 Chimeric Antigen Receptor T Cell Therapy in Children and Young Adults with Acute Lymphoblastic Leukemia. American Society of Hematology December 2023.
118 Freedman J, Phillips C, Wray L, Smith L, McGuire R, Bailer J: Enteral Nutrition Post Pediatric Hematopoietic Stem Cell Transplant. Multinational Association of Supportive Care in Cancer/JASCC/ISOO June 2023.
1ba Newman H, Li Y, Liu H, Myers RM, Tam V, DiNofia A, Wray L, Rheingold SR, Callahan C, White C, Baniewicz D, Winestone LE, Kadauke S, Diorio C, June CH, Getz KD, Aplenc R, Teachey DT, Maude SL, Grupp SA, Bona K, Leahy AB.: Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy. Blood 141: 609-619, Feb 2023.
2c
7
1d
1f
Selected Publications
12f Wray L, Myers R: CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy. Journal for ImmunoTherapy of Cancer Apr 2025.17e Friedes BD, DiNofia AM, Iannone E, Li Y, Rheingold SR, Leahy AB, Wray L, Callahan C, Baniewicz D, Vernau L, Getz KD, Aplenc R, Maude SL, Grupp SA, Myers RM.: Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy. Blood Adv 9: 354-359, Jan 2025.
1a3 Diorio C, Hernandez-Miyares L, Espinoza DA, Banwell BL, Bar-Or A, DiNofia AM, Barz Leahy A, Martinez Z, Myers RM, Hopkins SE, Rheingold SR, Teachey DT, Viaene AN, Wray LM, Maude SL, Grupp SA, McGuire JL.: Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents. Blood 144: 1387-1398, Sep 2024.
1d9 Myers RM, Devine K, Li Y, Lawrence S, Leahy AB, Liu H, Vernau L, Callahan C, Baniewicz D, Kadauke S, McGuire R, Wertheim GB, Kulikovskaya I, Gonzalez VE, Fraietta JA, DiNofia AM, Hunger SP, Rheingold SR, Aplenc R, June CH, Grupp SA, Wray L, Maude SL.: Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia. Blood Adv 8: 2182-2192, May 2024.
130 Oved JH, Gibson NM, Venella K, Elgarten CW, Wray L, Warren JT, Olson TS.: Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia. Front Immunol 15: 1369243, Feb 2024.
1d0 Elgarten CW, Heidemann S, Freedman JL, Grupp SA, Hankins P, Kadauke S, Li Y, McGlynn B, Olson TS, Wang Y, Wray L, Wang L, Seif AE, Bunin NJ: Pilot Study of Unrelated Donor (URD) Peripheral Stem Cell Transplant (PSCT) with CD45RA-Depleted Addback Following TCRab/CD19 Depletion in Pediatric Patients with Hematologic Malignancies Transplantation and Cellular Therapy 30(2): S9-S10, Feb 2024.
190 Gibson NM, Elgarten CW, Oved JH, Wray L, Freedman JL, Wang Y, Kadauke S, Hankins P, Nicholas P, Worster E, Kwiatkowski JL, Grupp SA, Bunin NJ, Olson TS: Outcomes of Unrelated Partial T Cell Depleted Stem Cell Transplantation for Patients with Hemoglobinopathies. Transplantation and Cellular Therapy 30(2): S301-S302, Feb 2024.
1e4 Myers RM, Mumanachit S, Maude SL, Dinofia AM, Freedman JL, Bunin N, Wray L, Barz AL, Olson TS, Grupp S, Seif AE, Elgarten CW: 3767 Outcomes and Toxicities after Allogeneic Hematopoietic Cell Transplant for Remission Consolidation or Relapse Therapy after CD19 Chimeric Antigen Receptor T Cell Therapy in Children and Young Adults with Acute Lymphoblastic Leukemia. American Society of Hematology December 2023.
118 Freedman J, Phillips C, Wray L, Smith L, McGuire R, Bailer J: Enteral Nutrition Post Pediatric Hematopoietic Stem Cell Transplant. Multinational Association of Supportive Care in Cancer/JASCC/ISOO June 2023.
1ba Newman H, Li Y, Liu H, Myers RM, Tam V, DiNofia A, Wray L, Rheingold SR, Callahan C, White C, Baniewicz D, Winestone LE, Kadauke S, Diorio C, June CH, Getz KD, Aplenc R, Teachey DT, Maude SL, Grupp SA, Bona K, Leahy AB.: Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy. Blood 141: 609-619, Feb 2023.
2c